Results
1
-
2
of
2
Wihler C; Sch?fer S; Schmid K; Deemer EK; M?nch G; Bleich M; Busch AE; Dingermann T; Somoza V; Baynes JW; Huber J.
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
,
Diabetologia
[DOI: 10.1007/s00125-005-1837-9]
The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy
,
Diabetologia
[DOI: 10.1007/s00125-003-1264-8]